🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Latest Xenotransplantation Literature Update (July–Dec 2024) — Overview of recent preclinical and clinical advancements, plus ethical, economic, and public health discussions onlinelibrary.wiley.com/doi/epdf/10.11… Joe M. Ladowski, MD PhD Kasra Shirini

Congrats to Dr. Babak Orandi, MD, PhD, MSc – a true Rising Star in Transplantation! As a skilled surgeon & founding director of the POWER Clinic, he's breaking barriers to organ transplant and living donation for his patients. Learn more about his work on our website:

Duke Surgery Duke General Surgery Residency doing big brainy 🧠 things: #1 in NIH funding among medical school surgery departments. surgery.duke.edu/news/duke-surg…

For the fourth year in a row Duke Surgery Duke General Surgery Residency rank #1 in NIH funding for departments of surgery. Including my research mentor Dr. Stuart Knechtle again demonstrating prowess as a surgeon-scientist and being #10 in the country! surgery.duke.edu/news/duke-surg…

Highly recommend American Journal of Transplantation SandyFeng

Welcome to the DukeSurgRes family!!

Funding cuts to the National Institutes of Health (NIH) put critical transplant research at risk. NIH-funded studies have driven advancements in transplantation, improving patient outcomes and paving the way for innovations like new immunosuppressants, immune tolerance

A significant milestone in Xenotransplantation: researchers in China have performed a pig-to-human liver transplant. The work, published nature marks a major step forward in xenotransplantation and raises new possibilities for addressing organ shortages nature.com/articles/s4158…

Happy CD3 CD28 T Cell Stimulation Day to all who celebrate #TCell #immunology

Proud of my wife and the work she’s doing at Duke Capital Partners!! Read all about it here: today.duke.edu/2025/03/10-yea…

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies globenewswire.com/news-release/2…

After a year of global collaboration, the IXA Position Paper on Kidney Xenotransplantation is now out in Transplantation and XenoTxJ. We outline clinical progress, ethical/regulatory insights, and evidence-based guidance for porcine kidney use in ESRD onlinelibrary.wiley.com/doi/10.1111/xe…

Joe M. Ladowski, MD PhD Muhammad Mansoor Mohiuddin Alexandre Loupy Burcin Ekser, MD, PhD ASTS journals.lww.com/transplantjour…

This collaborative work highlights the use of a new ABO antibody detection tool to expand donor options for ABO-O and ABO-B #transplant patients. We already use a single antigen bead-based approach for HLA antibodies. The time is now for ABO-histocompatibility. 🅰️🅱️🆎🅾️

He’s thriving nearly 4 months after receiving a gene-edited pig kidney at Mass General Transplant Mass General Surgery Mass General Kidneys Harvard Medical School. “He was tired of just surviving. A pig kidney gave him a shot at living.” CNN 🔗 cnn.com/2025/05/14/hea…

Congrats Anthony Saxton, MD MSc on your Annals of Surgery feature article on trends in medicare reimbursements for endocrine surgery!! Great work!! journals.lww.com/annalsofsurger… Duke Surgery American Association of Endocrine Surgeons

Truly grateful to receive American Association of Endocrine Surgeons Jon Van Heerden Award for Best Paper for our research on endocrine surgery #PriceTransparency and #CostOfCare @AAES2025! It was an honor to meet and learn from other residents, fellows, and global leaders in #EndocrineSurgery

Get ready for an unforgettable experience — IPITA 2025 is landing in Pisa! 🇮🇹 The countdown has officially begun… are you in? 😉 #IPITA2025

In this National Geographic article, discover the latest breakthroughs in the field of #xenotransplantation including contributions from our partner @eGenesis supported by our investigational #immunosuppression therapy tegoprubart: nationalgeographic.com/science/articl… $ELDN

Great news for the field! #Xenotransplantation's 2024 Impact Factor is 4.1 (up from 3.3) — now Q1 in #Transplantation and climbing in Experimental Medicine. A tremendous effort by all authors, reviewers, editors, and EIC leo buhler